Managing an unplanned gap in supply — setting out what I have, and where I think it stops being reliable.
A narrow question about managing an unplanned gap, deliberately narrow, because the broad version has been asked here four times and produced four long threads and no answer.
One question, stated units, stated method, and what I have already ruled out.
Adding the measurement that the opening post says would settle it.
Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
A weak preference rather than a position.
I had written a reply contradicting the opening post and deleted it. Here is what survived.
Where an alternative within the class is available, the comparison is a clinical one and the doses are not equivalent.
Noting that I have skin in this question and have tried to discount for it.
On managing an unplanned gap the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
An honest declaration on managing an unplanned gap: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
Coming back to post #3, because the follow-up matters more than the original answer.
Where I would push back on the managing an unplanned gap consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
The thing about managing an unplanned gap that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
What I want from this managing an unplanned gap thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Regional differences during a shortage are large, and a supply position in one country says nothing about another.
That holds for the case as described. Change the assumptions and it may not.
Thank you for taking the time. That was more work than a reply usually is.
Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
The mechanism is plausible, which is not the same as established.
Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your clinician is prudent if the gap is weeks or longer.
The confident version of this sentence would be wrong, so here is the hedged one.
Picking up post #16: that is the part I would want checked first.
I would put moderate confidence on the mainstream reading of managing an unplanned gap and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Noted, and I have changed what I was going to do on the strength of it.
Saving this. It is the version I will quote when the question comes round again.
Post #19 put the caveat in the right place and I want to underline it.
Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.
Nothing here is medical advice, and decisions about what to do during a supply interruption belong with a prescriber.
Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration discussion with a clinician.
Take it as a starting point and not as a specification.
The arithmetic in post #23 is right; the assumption feeding it is the part to check.
Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a date.
Someone should write this up properly, and it should probably not be me.
Something worth flagging about managing an unplanned gap: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a coincidence.
I have three months of notes on managing an unplanned gap and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion from the first fortnight.
Coming back to post #27, because the follow-up matters more than the original answer.
International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is prudent if you can.
Date any statement about supply. Positions change within weeks and the archive keeps posts permanently.